Wall Street Journal -- Your exploration of payments from medical-device manufacturers to surgeons (“Top Spine Surgeons Reap Royalties, Medicare Bounty,” page one, Dec. 20) offered a disturbing glimpse at the incentives and marketing practices of the device industry, but was, unfortunately, only the tip of the iceberg.
